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A b s t r a c t
Background: Clinical evaluation of patients with diabetes or after myocardial infarction (MI) with preserved left ventricular 
(LV) systolic function is not very precise in isolating patients at particularly high risk of developing manifest cardiac failure 
and associated cardiovascular incident. Early diagnosis of LV diastolic dysfunction is essential because implementation of the 
appropriate treatment can positively affect the course of the disease. 
Aim: To assess the impact of LV diastolic function on B-type natriuretic peptide (BNP) concentration at rest and immediately 
after exercise test, and to search for the relationship between LV diastolic function and BNP secretion, tolerance, and duration 
of exercise in the studied groups of patients.
Methods: Ninety-nine consecutive patients were qualified for the study: in Group 1 — patients with type 2 diabetes 
without a history of MI, and in Group 2 — patients after MI with preserved LV systolic function (ejection fraction ≥ 40%), 
without diabetes. The studied patients had echocardiography with LV systolic and diastolic function evaluation, an electro-
cardiographic exercise test and blood sampling for BNP determination before and immediately after exercise test.
Results: The study included 99 patients aged 40–75 years (60 patients after MI and 39 patients with diabetes). The study group 
included 62 patients who were diagnosed with diastolic dysfunction. Diastolic dysfunction occurred in 41 (68.4%) patients in 
the group after MI, and in 21 (53.8%) patients in the group with diabetes, severe disorders in the form of pseudonormal and 
restrictive mitral valve inflow occurred in 13 (21.7%) and five (12.8%), respectively. The average BNP concentration in patients 
with severe diastolic dysfunction at rest was 188.3 vs. 25.2 pg/mL in patients with normal diastolic function (p < 0.001). In 
all patients with severe diastolic dysfunction BNP after exercise was 285.2 vs. 37.5 pg/mL in patients with normal diastolic 
function, and the increase in BNP during exercise was 96.9 vs. 12.4 pg/mL, respectively. Duration of exercise and exercise 
tolerance in patients with normal diastolic function was better in comparison with the studied patients with disturbed diastolic 
function, but did not reach statistical significance. 
Conclusions: The BNP initial concentration and its value immediately after exercise were significantly higher in subjects with 
severe diastolic disorders than those in subjects with normal LV diastolic function and in subjects with impaired LV relaxation.
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INTRODUCTION
Clinical evaluation of patients with diabetes or after myocar-
dial infarction (MI) with preserved left ventricular (LV) systolic 
function is not very precise in isolation of patients particularly 
at risk of developing manifest cardiac failure and associated 
cardiovascular incident.
Left ventricular diastolic dysfunction (LVDD) with pre-
served ejection fraction (EF) without accompanying clinical 
symptoms is the first stage of diabetic cardiomyopathy and 
link in the pathogenesis of LV remodelling after MI [1, 2]. 
Early diagnosis of LVDD is essential because implementation 
of appropriate treatment can positively affect the course of 
the disease. Doppler and tissue echocardiography remains 
the most widely used non-invasive method of assessing LV 
diastolic function. It enables precise positioning of several 
stages of diastolic dysfunction [3].
For the evaluation of LV diastolic function, measuring the 
strain rate and stress echocardiography can be used.
Also, B-type natriuretic peptide (BNP) has an established 
position in the detection of asymptomatic LVDD, and its level 
is proportional to the severity of LVDD [4, 5].
Stress test is a clinically useful method of assessing exercise 
tolerance and assessing the risk of ischaemia. Using three diag-
nostic methods: echocardiography, stress test, and measuring 
concentrations of natriuretic peptides allows for more accurate 
assessment of patients and allows for more effective treatment.
Low BNP concentrations have a high negative predictive 
value at the exclusion of heart failure (HF). The BNP cut-off 
value in patients with acute dyspnoea is below 100 pg/mL 
and in patients with a slow development of cardiac failure 
symptoms, BNP levels < 35 pg/mL [3].
B-type natriuretic peptide is a neurohormone synthesised 
by the myocardium and released in response to myocardial 
wall stretch due to increased volume or intracardiac pressure. 
BNP plays a role in preventing volume overload through the 
renin–angiotensin–aldosterone system inhibition, and it has 
natriuretic, diuretic and vasodilating effects [6]. 
Survival of patients with type 2 diabetes without MI is 
similar to patients without diabetes after MI [7]. It was in 
the Framingham study, for the first time, that an association 
between diabetes and HF was found [8]. Data from the 
Framingham study showed that the mortality rate in LVDD is 
8.9% compared with 3.7% in the control group. Consequently, 
diabetics should be treated as a very high cardiovascular risk 
group requiring secondary prevention.
In connection with a similar prognosis of patients with 
diabetes and patients after MI without diabetes, it was decided 
to compare the subjects in those two groups.
The aim of the study was to assess the impact of LV dias-
tolic function on BNP concentration at rest and immediately 
after stress test and to search for the relationship between 
LV diastolic function and BNP secretion, and tolerance and 
duration of exercise in the studied groups of patients.
METHODS
Study group
Subjects qualified for the study were patients with type 2 dia-
betes without a history of MI (Group 1) and patients after MI 
treated with primary angioplasty, with preserved LV systolic 
function (EF ≥ 40%) in the period from three months to one 
year after acute MI (Group 2). The exclusion criteria of the study 
were: LVEF < 40%, valvular heart disease, also after adjustment, 
atrial fibrillation, and acute MI within three months after the MI.
The study included 99 patients aged 40–75 years: 
39 patients with diabetes and 60 with a history of acute MI. 
All patients had preserved LV systolic function (LVEF ≥ 40%).
The patients currently did not have symptoms of car-
diac failure, were undergoing optimal medical therapy, and 
diabetes was controlled. Medication of the studied patients: 
angiotensin converting enzyme inhibitors (ACEI) — 71 (72%), 
sartans — 8 (8%), beta-blockers — 42 (%), statins — 69 (70%), 
diuretics — 14 (14%), insulin — 24 (24%), oral hypoglycae-
mics — 25 (25%), acetylsalicylic acid (ASA) — 64 (65%). Some 
cardiology drugs (diuretics, ACEI, beta-blockers) may reduce 
BNP levels, but their percentage distribution was proportional 
in the study groups.
The patients included in the study were a group of out-
patients in the Regional Diabetes Clinic and in the Clinical 
Department of the Swietokrzyskie Cardiology Centre.
The study was approved by the Bioethics Committee of 
the Medical Chamber of Kielce No. 11/2005. All the subjects 
were previously informed in detail about the study purpose 
and method, and a signed written consent to participate in 
the research was obtained from each patient. 
Echocardiography
Left ventricular diastolic function assessment was done based 
on echocardiography with the following parameters deter-
mination: mitral inflow profile (peak E wave velocity [E], the 
maximum speed of A wave [A], E/A ratio, E wave deceleration 
time [DT]) and tissue Doppler parameters (early diastolic mitral 
annulus velocity e’), as well as the E/e’ index — the ratio of 
the maximum velocity of early mitral inflow to early diastolic 
mitral annulus velocity. In order to distinguish normal from 
pseudonormal inflow profile, the pulmonary veins flow profile 
was analysed (the S/D ratio, the amplitude of the Ar wave 
[Ar-atrial reversal], and the difference between the duration 
of wave A inflow in the pulmonary vein, and mitral inflow 
wave A duration [Ar-A]) and the change of the E/A ratio during 
the Valsalva manoeuver (Val DE/A).
The following criteria of LVDD diagnosis were adopted 
[3, 9]:
 — normal LV diastolic function (e’septal ≥ 8, left atrial vol-
ume index < 34 mL/m2);
 — mild diastolic dysfunction (grade I): e’septal < 8, E/A < 0.8, 
DT > 200 ms, E/e’ ≤ 8, Ar-A < 0 ms, Val DE/A < 50%;
 — severe diastolic dysfunction (grade II and III): 
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• pseudonormalisation of mitral inflow: e’septal < 8, 
E/A 0.8–1.5, DT 160–200 ms, E/e’ 9–12, Ar-A ≥ 30 ms, 
Val DE/A ≥ 50%;
• restrictive mitral inflow: e’septal < 8, E/A ≥ 2, 
DT < 160 ms, E/e’ ≥ 13, Ar-A ≥ 30 ms, Val DE/A ≥ 50%.
Left ventricular hypertrophy (LVH) was diagnosed on 
the basis of septal thickness (IVS) in the long-axis parasternal 
view (IVS ≥ 12 mm).
Stress test
The stress test was performed on a treadmill, according to 
the Bruce protocol, with the use of a Marquette Electronics 
Case 8000 treadmill. Immediately before and after the test, 
the concentrations of BNP were determined.
Blood pressure (BP) and heart rate (HR) were taken at rest 
and immediately after maximal exercise. The test was termi-
nated once the studied age-appropriate submaximal HR was 
achieved or fatigue or symptoms of angina with ST-segment 
depression on electrocardiogram were present.
Biochemical assays
Blood samples for determination of resting BNP were col-
lected from the antecubital vein after 30 min of rest before 
performing the stress test, and immediately after the test. 
Plasma BNP was determined by enzyme immunoassay, and 
the measurement was performed on an automated analyser. 
BNP concentrations were determined using the Beckman 
Coulter Immunoassay system.
Statistical analysis
The statistical description of quantitative variables was made 
with the use of the mean, the standard deviation (SD), and 
the median. Qualitative variables were characterised by 
specifying the size of each of the variants and its percentage of 
the group under consideration. For comparison of the mean 
values of the quantitative variable in both groups the Student’s 
t-test was used. For a larger number of groups, the F test of 
analysis of variance as well as the Tukey and Duncan multiple 
comparison tests were applied. The nonparametric analysis 
of variance and the Kruskal-Wallis tests were used when the 
distribution of a quantitative variable showed a significant 
deviation from the normal distribution. To compare groups 
of patients in terms of a qualitative variable the c2 independ-
ence test was used.
In statistical inference the significance level of 0.05 was 
adopted. Statistical analyses were performed using SAS 9.3 li-
censed software.
RESULTS
The study included 99 consecutive patients after MI, without 
diabetes, and with EF ≥ 40% (Group 1), as well as patients with 
type 2 diabetes, without a history of MI (Group 2).
Table 1 presents LV diastolic function parameters in the 
study group. Diastolic dysfunction occurred in 41 (68.4%) 
patients in the group after MI, and in 21 (53.8%) patients 
in the group with diabetes; severe disorders in the form of 
pseudonormal and restrictive mitral valve inflow occurred in 
13 (21.7%) vs. 5 (12.8%) (Table 2). 
In patients with diabetes and after MI with preserved LV 
systolic function, BNP secretion increase was demonstrated 
during the exercise test.
The difference of the average BNP increase in the whole 
group and in the groups after MI and with diabetes was 
statistically significant (p < 0.001). The ends of the confi-
dence intervals for the mean increase in BNP, obtained for 
a confidence level of 0.95, were as follows: the entire group 
— 1.98; 38.14, the diabetes group — 9.41; 26.80, patients 
after MI — 5.98; 49.68. 
B-type natriuretic peptide concentration before the 
stress test for the entire group was 63.1 ± 83 pg/mL, at peak 
Table 1. Echocardiography parameters
Parameter tested Study group (n = 99) P 
Subjects after myocardial  
infarction (n = 60)
Diabetics  
(n = 39)
E [cm/s] 66.0 ± 21.3 62.6 ± 14.5 0.35
A [cm/s] 77.2 ± 17.8 74.2 ± 16.8 0.39
E/A ratio 0.9 ± 0.4 0.9 ± 0.4 0.89
Deceleration time [ms] 226.5 ± 57.8 232.3 ± 82 0.70
e’ septal [cm/s] 7.5 ± 2.7 7.2 ± 2.6 0.55
E/e’ index 9.8 ± 5.7 9.6 ± 3.4 0.87
Left atrial volume index [mL/m2] 35.3 ± 2.8 35.8 ± 4.7 0.88
Ejection fraction [%] 51.2 ± 6.4 61.9 ± 3.9 < 0.001
Data are presented as mean ± standard deviation; E — maximum E wave velocity; A — maximum A wave velocity; e’ septal — early diastolic 
mitral annulus velocity; E/e’ index — the ratio of the maximum velocity of early mitral inflow to early diastolic mitral annulus velocity
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The average concentrations of BNP in subjects with severe 
diastolic dysfunction at rest amounted to 188.3 vs. 25.2 pg/mL 
in patients with normal LV diastolic function, and immediately 
after exercise 285.2 vs. 37.5 pg/mL. The increase in BNP dur-
ing exercise was 96.9 vs. 12.4 pg/mL (Table 4).
Both in patients with diabetes and in those with MI the 
average concentrations of BNP were significantly higher in 
subjects with severe diastolic dysfunction. Relationships be-
tween LV diastolic function and BNP in the group with diabe-
tes are shown in Table 5, and in the group after MI in Table 6.
Severe abnormality in diastolic function was observed 
more frequently in older patients (p = 0.05) and in subjects 
with EF < 50% (p < 0.001). Duration of exercise and exer-
exercise 93.2 ± 116.6 pg/mL, and the mean BNP increase 
was 30.1 ± 40.5 pg/mL.
B-type natriuretic peptide concentration before the stress 
test in the group with a history of MI was 71.1 ± 93.8 pg/mL, 
and in the group with diabetes 51.0 ± 62.4 pg/mL.
The average BNP concentration after exercise and BNP 
increase during exercise were higher in patients after MI. The 
exercise resulted in an average BNP increase in subjects after 
acute MI of 37.8 ± 45.9 pg/mL and in subjects with diabetes, 
18.1 ± 26.8 pg/mL (Table 3).
The average BNP concentrations at rest and at peak 
exercise, as well as BNP increase during the exercise, were sig-
nificantly higher in subjects with severe diastolic dysfunction. 
Table 2. Assessment of left ventricular (LV) diastolic function in study groups
LV diastolic function Study group (n = 99) P
Subjects after myocardial  
infarction (n = 60)
Diabetics  
(n = 39) 
Normal 19 (31.7%) 18 (46.2%)
0.28Mildly impaired 28 (46.7%) 16 (41.0%)
Severely impaired 13 (21.7%) 5 (12.8%)
Table 3. B-type natriuretic peptide (BNP) concentrations in study groups
Subjects after myocardial  
infarction (n = 60)
Diabetics
(n  = 39)
P*
BNP before exercise test [pg/mL] 71.1 ± 93.8 51.0 ± 62.4 0.20
BNP after exercise test [pg/mL] 108.9 ± 133.2 69.1 ± 80.9 0.07
Growth of BNP [pg/mL] 37.8 ± 45.9 18.1 ± 26.8 0.01
Data are presented as mean ± standard deviation; *p — multiple comparison test
Table 4. B-type natriuretic peptide (BNP) concentrations in the whole study group
Normal diastolic  






BNP before exercise test [pg/mL] 25.2 ± 18.8 43.9 ± 27.1 188.3 ± 128.3 < 0.001
BNP after exercise test [pg/mL] 37.5 ± 21.7 61.5 ± 35.6 285.2 ± 160.8 < 0.001
Growth of BNP [pg/mL] 12.4 ± 9.7 17.6 ± 16.2 96.9 ± 52.7  < 0.001
Data are presented as mean ± standard deviation; *p — multiple comparison test 
Table 5. B-type natriuretic peptide (BNP) concentrations in the group with diabetes
Normal diastolic  






BNP before exercise test [pg/mL] 26.0 ± 22.2 48.1 ± 36.8 150.0 ± 121.3 < 0.001
BNP after exercise test [pg/mL] 37.8 ± 25.3 59.6 ± 44.4 223.2 ± 129.4 < 0.001
Growth of BNP [pg/mL] 8.8 ± 6.9 11.4 ± 9.6 73 ± 44.0 < 0.001
Data are presented as mean ± standard deviation; *p — multiple comparison test
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cise tolerance (expressed in METS) in subjects with normal 
diastolic function was better in comparison with the studied 
patients with impaired diastolic function, but it did not reach 
statistical significance. In the study group hypertension oc-
curred in 29 (74.4%) patients with diabetes and in 40 (66.7%) 
patients with a history of MI (p = 0.41). LVH was present in 
13 (33.3%) patients with diabetes and in 23 (38.3%) after 
MI (p = 0.61). There was a statistically significant impact of 
LVH on LV diastolic dysfunction (p < 0.001). Among the 
risk factors for cardiovascular disease, hypertension and 
hypercholesterolaemia were more frequent in subjects with 
impaired diastolic function compared to subjects with normal 
function (Table 7).
DISCUSSION
Left ventricular diastolic dysfunction, due to the asymptomatic 
nature at its early stage, is usually not diagnosed or treated, 
which leads to progressive myocardial injury, the development 
of manifest cardiac failure, and associated cardiovascular 
events. Early diagnosis of diastolic dysfunction of the LV is 
important, since the implementation of appropriate treatment 
may favourably affect the prognosis [10].
Kato et al. [11] compared the BNP response to exercise 
in patients with asymptomatic LV dysfunction, in patients with 
cardiac failure and in the control group. The authors demon-
strated that the absolute increase, and more importantly the 
BNP increase adjusted for  increase in load (determined by the 
ratio of the increase in BNP to the increase in maximum oxy-
gen uptake during exercise), was higher with LV dysfunction 
and significantly higher in patients with cardiac failure [11].
In the presented study, the mean concentrations of BNP 
at rest and at peak exercise, as well as the BNP increase dur-
ing exercise, were significantly higher in subjects with severe 
diastolic dysfunction.
Several scientific studies evaluated the value of BNP in 
the diagnosis of diastolic dysfunction compared with conven-
tional echocardiography. Significantly higher levels of BNP 
and NT-proBNP were detected in patients with advanced 
diastolic dysfunction. However, it was found that these pep-
tides correlate with severe diastolic dysfunction, while their 
Table 6. B-type natriuretic peptide (BNP) concentrations in the group after myocardial infarction
Normal diastolic  






BNP before exercise test [pg/mL] 24.4 ± 15.4 41.5 ± 19.9 203.0 ± 132.7 < 0.001
BNP after exercise test [pg/mL] 40.2 ± 18.0 62.6 ± 30.3 309.1 ± 169.7 < 0.001
Growth of BNP [pg/mL] 15.8 ± 10.8 21.1 ± 16.2 106.1 ± 54.4 < 0.001
Data are presented as mean ± standard deviation; *p — multiple comparison test
Table 7. The relationship between left ventricular diastolic function and selected parameters in the whole study group
Parameter Normal diastolic  






Age [years] 53.5 ± 6.5 55.6 ± 8.0 58.7 ± 6.9 0.05
Age > 60 years 61.8 ± 1.2 65.3 ± 0.8 72.2 ± 1.1 0.001
Body mass index 28.3 ± 4.0 28.4 ± 4.3 28.4 ± 3.5 0.99
Ejection fraction [%] 59.0 ± 6.2 55.4 ± 6.4 48.2 ± 8.3 < 0.001
Metabolic equivalent of task 8.8 ± 2.1 8.0 ± 2.4 8.2 ± 2.5 0.26
Exercise time [min] 7.1 ± 2.1 6.3 ± 2.3 6.5 ± 2.6 0.32
HR at rest [bpm] 78.2 ± 10.8 81.5 ± 17.6 73.3 ± 16.7 0.15
HR max [bpm] 134.8 ± 19.5 133.0 ± 14.1 128.7 ± 17.9 0.45
Max systolic BP [mm Hg] 165.1 ± 23.3 163 ± 22.9 169 ± 28 0.67
ST depression 6 (16.3%) 11 (25%) 5 (27.8%) 0.52
Smoking 15 (40.5%) 14 (31.8%) 6 (33.3) 0.70
Arterial hypertension 24 (64.9%) 32 (72.7 %) 13 (72.2%) 0.72
Hypercholesterolaemia 24 (64.9%) 32 (72.7%) 13 (72.2%) 0.93
Left ventricular hypertrophy 5 (13.5%) 24 (54.5%) 7 (38.9%) < 0.001
Data are presented as mean ± standard deviation or number and percentage (in brackets); BP — blood pressure; HR — heart rate; *p — multiple 
comparison test
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role in detecting moderate diastolic HF is uncertain. Lubien et 
al. [12] found that BNP levels were elevated in patients with 
exertional dyspnoea and impaired LV relaxation (202 pg/mL).
Mottram et al. [13] also found increased BNP levels in 
patients with hypertension induced LV relaxation disorders as 
compared with the control group; however, the BNP levels of 
over 75% of patients with impaired relaxation participating in 
this study were within the normal range (89 pg/mL).
Hypertension can lead to HF through increased after-
load, LVH, fibrosis, and impaired LV diastolic filling. Diastolic 
dysfunction assessed by echocardiography is an independent 
factor for the development HF and sudden cardiac death [14].
Wei et al. [15] indicated low but significantly elevated 
levels of BNP in diastolic dysfunction caused by hypertension, 
which showed moderate sensitivity but high specificity in 
detecting diastolic dysfunction in hypertensive patients. Simi-
larly, Dahlstrom [16] demonstrated only a tendency towards 
elevated levels of both BNP and NT-proBNP in patients with 
minor alterations of diastolic dysfunction indices in Doppler 
echocardiography. Also, Tschope et al. [17] demonstrated 
that the concentration of NT-proBNP was elevated in patients 
with diastolic dysfunction and preserved systolic function and 
correlated with the severity of the disease.
Levels of NT-proBNP showed similar diagnostic accuracy 
for diastolic HF as measured by tissue Doppler imaging, and 
they were a better diagnostic parameter of diastolic dysfunc-
tion than conventional echocardiography [17]. 
Left ventricular diastolic dysfunction with preserved sys-
tolic function without accompanying clinical symptoms may 
be the first stage of diabetic cardiomyopathy. In the Strong 
Heart Study diabetes associated LVDD was similar to that as-
sociated with hypertension, but it was more severe in patients 
with both diseases [18].
Depending on the echocardiographic criteria used in 
the definition, LVDD is found in 30–75% of diabetics [19]. 
Boyer et al. [20] diagnosed diastolic dysfunction in 47% of 
asymptomatic patients with type 2 diabetes but with normal 
blood pressure values, while Valle et al. [21] documented 
subclinical LV diastolic dysfunction in 51.3% of diabetics with 
normal LV systolic function.
In the presented study diastolic dysfunction occurred 
in 53.8% of diabetics, and in the group after MI 68.4% had 
abnormal diastolic function, including 13% with severe dis-
orders. Diastolic dysfunction was significantly more frequent 
in subjects with LVH. In the population study Hurk et al. [22] 
showed that in asymptomatic patients with type 2 diabetes, 
elevated concentrations of BNP, but below the threshold of 
100 pg/mL, were significantly associated with increased LV 
mass and deterioration of its diastolic function, independent 
of cardiovascular disease traditional risk factors. In the present 
study, BNP concentration in patients with diabetes and severe 
diastolic dysfunction was 150 pg/mL and was significantly 
higher than in subjects with normal diastolic function or 
mild diastolic dysfunction. Similar results were obtained by 
Magnusson et al. [23], who demonstrated that the BNP level 
determination proved to be useful for the identification of 
patients with severe diastolic dysfunction. Impaired relaxation 
can be a symptom of myocardial ischaemia due to limited 
supply of energy. According to Apstein et al. [24], ischaemia 
caused by increased demand for oxygen provokes diastolic 
dysfunction. The significant improvement in diastolic filling in 
patients undergoing coronary revascularisation confirms the 
importance of ischaemia in the pathogenesis of the diastolic 
dysfunction. Deterioration of energy substrate-dependent ac-
tive relaxation, reduction of compliance as a result of fibrotic 
changes, heterogeneity of load, and the inactivation caused 
by segmental abnormalities in LV systolic and diastolic func-
tion are of major importance in the mechanism of diastolic 
dysfunction in ischaemic heart disease.
In the present study, severe diastolic dysfunction was 
more frequent in older subjects. Boonman-de Winter 
et al. [25] demonstrated that 28% of type 2 diabetics, 
aged > 60 years, had previously undetected HF, 5% of whom 
had reduced LVEF, and 23% had preserved LVEF [25]. In heart 
failure with preserved ejection fraction (HF-PEF) patients, age 
was considered to be one of the most important prognostic 
factors. The five-year mortality rate in patients with HF-PEF 
aged < 50 years was 15%. In patients aged 50–70 years 
the rate was 33%, and in the group over 70 years of age it 
exceeded 50% [10]. Also, the Digitalis Investigation Group 
study demonstrated older age as an important predictor of 
mortality in HF-PEF patients [10].
Limitations to the study
An undoubted limitation to the study is the small number of 
patients in the study groups. In the assessment of LV diastolic 
function strain rate was not used and neither was stress echo-
cardiography, due to the lack of universally accepted criteria 
for diagnosis of diastolic dysfunction using these parameters 
and lack of data defining their diagnostic accuracy.
CONCLUSIONS
1. B-type natriuretic peptide concentration was significantly 
higher in subjects with severe diastolic dysfunction as 
compared with subjects with normal diastolic function 
and subjects with impaired LV relaxation.
2. The concentration of BNP at peak exercise, as well as 
the increase in BNP during the exercise, was signifi-
cantly higher in subjects with severely impaired diastolic 
function. 
3. Duration and exercise tolerance were worse in patients 
with impaired diastolic function, compared with those 
in the study patients with normal diastolic function, but 
they did not reach statistical significance.
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Wpływ czynności rozkurczowej lewej komory na 
wydzielanie peptydu natriuretycznego typu B  
w spoczynku i bezpośrednio po próbie 
wysiłkowej u bezobjawowych pacjentów  
z cukrzycą oraz po przebytym zawale serca  
z zachowaną funkcją skurczową lewej komory
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S t r e s z c z e n i e
Wstęp: Kliniczna ocena chorych na cukrzycę lub po przebytym zawale serca z zachowaną funkcją skurczową lewej komory (LV) jest mało 
precyzyjna w wyodrębnianiu osób szczególnie zagrożonych rozwojem jawnej niewydolności serca czy incydentem sercowo-naczyniowym. 
Dysfunkcja rozkurczowa LV z zachowaną funkcją skurczową bez towarzyszących objawów klinicznych może stanowić pierwszy etap kardio-
miopatii cukrzycowej i ogniwo w patogenezie remodelingu LV po przebytym zawale serca. Wczesne rozpoznanie rozkurczowej dysfunkcji LV 
ma istotne znaczenie, ponieważ wdrożenie odpowiedniego postępowania może korzystnie wpłynąć na przebieg choroby. Echokardiografia 
doplerowska i tkankowa pozostają najpowszechniej stosowanymi nieinwazyjnymi metodami oceny czynności rozkurczowej LV. Umożliwiają 
precyzyjne wyróżnienie kilku stadiów dysfunkcji rozkurczowej. Peptyd natriuretyczny typu B (BNP) ma ugruntowaną pozycję w wykrywaniu 
bezobjawowych zaburzeń czynności rozkurczowej LV, a jego stężenie jest proporcjonalne do stopnia zaawansowania zaburzeń czynności 
rozkurczowej. BNP to neurohormon syntetyzowany przez mięśniówkę komór i uwalniany w odpowiedzi na rozciągnięcie ściany miokardium 
na skutek zwiększonej objętości czy ciśnienia wewnątrzsercowego. BNP odgrywa rolę w zapobieganiu przeciążeniu objętościowemu poprzez 
zahamowanie układu renina–angiotensyna–aldosteron, działa natriuretycznie, moczopędnie i rozszerza naczynia krwionośne. Obecność 
dysfunkcji rozkurczowej LV po zawale serca może się wiązać z występowaniem remodelingu, niewydolności serca i pogorszeniem rokowania 
w tej grupie chorych, niezależnie od upośledzonej funkcji skurczowej LV. Cukrzyca stanowi niezależny czynnik ryzyka rozwoju niewydolności 
serca. Jest coraz więcej doniesień wskazujących na istotną rolę peptydów natriuretycznych w wykrywaniu bezobjawowych zaburzeń czynności 
rozkurczowej LV oraz w stratyfikacji ryzyka u tych pacjentów.
Cel: Celem badania była ocena wpływu funkcji rozkurczowej LV na stężenie BNP w spoczynku i bezpośrednio po zakończeniu próby wysił-
kowej oraz poszukiwanie zależności między funkcją rozkurczową LV a wydzielaniem BNP, tolerancją i czasem trwania wysiłku w badanych 
grupach chorych.
Metody: Do badania kwalifikowano kolejnych pacjentów z cukrzycą typu 2 bez wywiadu zawału serca oraz chorych po przebytym zawale 
serca z zachowaną funkcją skurczową LV (EF ≥ 40%). Wykonywano badanie echokardiograficzne z oceną funkcji skurczowej i rozkurczowej 
LV, elektrokardiograficzną próbę wysiłkową oraz pobierano krew w celu oznaczenia BNP przed testem wysiłkowym i bezpośrednio po nim. 
Wyniki: Do badania włączono 99 pacjentów w wieku 40–75 lat (60 osób po zawale serca i 39 chorych na cukrzycę); zaburzenia funkcji 
rozkurczowej rozpoznawano u 62 badanych. W grupie po przebytym zawale serca u 41 (68,4%) osób występowały zaburzenia funkcji roz-
kurczowej, a w grupie pacjentów z cukrzycą — u 21 (53,8%) badanych, w tym ciężkie zaburzenia u 13 (21,7%) vs. 5 (12,8%) odpowiednio 
pod postacią pseudonormalnego i restrykcyjnego napływu mitralnego. Średnie stężenie BNP u chorych z ciężkimi zaburzeniami funkcji roz-
kurczowej w spoczynku wynosiło 188,3 pg/ml vs. 25,2 pg/ml u badanych z prawidłową funkcją rozkurczową LV (p = 0,0001). Czas trwania 
próby i tolerancja wysiłku (METS) u badanych z prawidłową funkcją rozkurczową były lepsze niż u osób z zaburzeniami funkcji rozkurczowej, 
ale nie osiągnęły istotności statystycznej.
Wnioski: Stężenie BNP wyjściowe oraz bezpośrednio po zakończeniu wysiłku było istotnie wyższe u badanych z ciężkimi zaburzeniami 
funkcji rozkurczowej w porównaniu z pacjentami z prawidłową funkcją rozkurczową LV i z osobami z upośledzoną relaksacją.
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